sitamaquine has been researched along with miltefosine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castanys, S; Castanys-Muñoz, E; Gamarro, F; Pérez-Victoria, JM | 1 |
Alvarez, A; Arvelo, F; Bompart, D; García-Marchán, Y; Kouznetsov, VV; Meléndez Gómez, CM; Núñez-Durán, J; Rodríguez, D; Serrano-Martín, X; Sojo, F; Visbal, G | 1 |
Azas, N; Castera-Ducros, C; Cohen, A; Hutter, S; Kieffer, C; Laget, M; Paloque, L; Rathelot, P; Rault, S; Valentin, A; Vanelle, P; Verhaeghe, P | 1 |
Lombardo, M; Ortalli, M; Quintavalla, A; Rosso, C; Trombini, C; Varani, S | 1 |
4 other study(ies) available for sitamaquine and miltefosine
Article | Year |
---|---|
Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; ATP-Binding Cassette Transporters; Base Sequence; Biological Transport, Active; Chloroquine; DNA, Protozoan; Drug Resistance; Fluorescent Dyes; Genes, Protozoan; Humans; Leishmania infantum; Leishmaniasis, Visceral; Lipid Bilayers; Phosphorylcholine; Protozoan Proteins; Recombinant Proteins; Transformation, Genetic | 2008 |
Anti-leishmanial evaluation of C2-aryl quinolines: mechanistic insight on bioenergetics and sterol biosynthetic pathway of Leishmania braziliensis.
Topics: Animals; Antiparasitic Agents; Energy Metabolism; Leishmania braziliensis; Life Cycle Stages; Macrophages; Molecular Structure; Quinolines | 2013 |
Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series.
Topics: Antiprotozoal Agents; Drug Design; Hep G2 Cells; Humans; Leishmania donovani; Leishmania infantum; Life Cycle Stages; Macrophages; Nitroquinolines; Parasitic Sensitivity Tests; Pentamidine; Phosphorylcholine; Structure-Activity Relationship | 2015 |
Evaluation of synthetic substituted 1,2-dioxanes as novel agents against human leishmaniasis.
Topics: Animals; Chlorocebus aethiops; Dioxanes; Drug Design; Humans; Leishmania; Leishmaniasis; Parasitic Sensitivity Tests; Trypanocidal Agents; Vero Cells | 2019 |